How Fecal DNA Testing can Help with Early Detection of Colorectal Cancer
COLOTECTTM 1.0 is a non-invasive fecal DNA test developed by BGI Genomics for detecting colorectal cancer and precancerous lesions.
Stay updated with breaking news from Diagnostic Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COLOTECTTM 1.0 is a non-invasive fecal DNA test developed by BGI Genomics for detecting colorectal cancer and precancerous lesions.
Comparing the diagnostic performance of pathogens between mNGS and BALF culture in patients with lower respiratory tract infections in China.
/PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products...
/PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products...
Comparison of the Diagnostic Performance of a Rapid Antigen Test with Real-Time Polymerase Chain Reaction for Detection of SARS-CoV-2 Among Patients Diagnosed with COVID-19 at Selected Hospitals in Addis Ababa, Ethiopia